Thrombotic microangiopathy (TMA) is one of the severe complications after stem cell transplantation (SCT) and is associated with graft-versus-host disease (GVHD) prophylaxis including FK506. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback